Data from Preclinical and Clinical Evidence that Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography with Computed Tomography Is a Reliable Tool for the Detection of Early Molecular Responses to Erlotinib in Head and Neck Cancer
Authors:
- Sébastien VergezSVSébastien Vergez
- Jean-Pierre DelordJean-Pierre Delord
- Fabienne ThomasFTFabienne Thomas
- Philippe RochaixPRPhilippe Rochaix
- Olivier CasellesOCOlivier Caselles
- Thomas FilleronTFThomas Filleron
- Séverine BrillouetSBSéverine Brillouet
- Pierre CanalPCPierre Canal
- Frédéric CourbonFCFrédéric Courbon
- Ben C. AllalBABen C. Allal
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)